Cargando…
Formulation and evaluation of transparent ibuprofen soft gelatin capsule
The compound ibuprofen, 2-(4-isobutylphenyl) propionic acid, has been known e.g. from Martindale, the Extra Pharmacopoeia, 28(th) edition, 1982, p.256, as a drug which had anti-inflammatory and analgesic properties. It is used for the treatment of rheumatoid arthritis or other inflammatory diseases...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467835/ https://www.ncbi.nlm.nih.gov/pubmed/23066224 http://dx.doi.org/10.4103/0975-7406.94154 |
_version_ | 1782245880777146368 |
---|---|
author | Lodha, A. Patel, A. Chaudhuri, J. Jadia, P. Joshi, T. Dalal, J. |
author_facet | Lodha, A. Patel, A. Chaudhuri, J. Jadia, P. Joshi, T. Dalal, J. |
author_sort | Lodha, A. |
collection | PubMed |
description | The compound ibuprofen, 2-(4-isobutylphenyl) propionic acid, has been known e.g. from Martindale, the Extra Pharmacopoeia, 28(th) edition, 1982, p.256, as a drug which had anti-inflammatory and analgesic properties. It is used for the treatment of rheumatoid arthritis or other inflammatory diseases of joints, soft tissue rheumatism and gout. Ibuprofen, because of its analgesic properties, has been widely used as anodyne, e.g. against pain or discomfort associated with headache, toothache or menstruation. A medication suitable to combat acute pain is demanded to display its effects fast which action, in turn, is only achieved by a quick release and good bio-availability of the active-ingredient. It is for the commercial forms in particular that the conditions of preparation must be strictly observed, as minor alterations in production procedures such as mixing, pressure of compression and type of machine will affect the physical properties of the particles of he active ingredient and will deteriorate its bio-availability. It is an object of this presentation to provide a medicament that can be readily taken that contains an active amount of ibuprofen in a carrier, that is simple to prepare and that will quickly display a high activity. |
format | Online Article Text |
id | pubmed-3467835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-34678352012-10-12 Formulation and evaluation of transparent ibuprofen soft gelatin capsule Lodha, A. Patel, A. Chaudhuri, J. Jadia, P. Joshi, T. Dalal, J. J Pharm Bioallied Sci Original/Brief The compound ibuprofen, 2-(4-isobutylphenyl) propionic acid, has been known e.g. from Martindale, the Extra Pharmacopoeia, 28(th) edition, 1982, p.256, as a drug which had anti-inflammatory and analgesic properties. It is used for the treatment of rheumatoid arthritis or other inflammatory diseases of joints, soft tissue rheumatism and gout. Ibuprofen, because of its analgesic properties, has been widely used as anodyne, e.g. against pain or discomfort associated with headache, toothache or menstruation. A medication suitable to combat acute pain is demanded to display its effects fast which action, in turn, is only achieved by a quick release and good bio-availability of the active-ingredient. It is for the commercial forms in particular that the conditions of preparation must be strictly observed, as minor alterations in production procedures such as mixing, pressure of compression and type of machine will affect the physical properties of the particles of he active ingredient and will deteriorate its bio-availability. It is an object of this presentation to provide a medicament that can be readily taken that contains an active amount of ibuprofen in a carrier, that is simple to prepare and that will quickly display a high activity. Medknow Publications & Media Pvt Ltd 2012-03 /pmc/articles/PMC3467835/ /pubmed/23066224 http://dx.doi.org/10.4103/0975-7406.94154 Text en Copyright: © Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original/Brief Lodha, A. Patel, A. Chaudhuri, J. Jadia, P. Joshi, T. Dalal, J. Formulation and evaluation of transparent ibuprofen soft gelatin capsule |
title | Formulation and evaluation of transparent ibuprofen soft gelatin capsule |
title_full | Formulation and evaluation of transparent ibuprofen soft gelatin capsule |
title_fullStr | Formulation and evaluation of transparent ibuprofen soft gelatin capsule |
title_full_unstemmed | Formulation and evaluation of transparent ibuprofen soft gelatin capsule |
title_short | Formulation and evaluation of transparent ibuprofen soft gelatin capsule |
title_sort | formulation and evaluation of transparent ibuprofen soft gelatin capsule |
topic | Original/Brief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467835/ https://www.ncbi.nlm.nih.gov/pubmed/23066224 http://dx.doi.org/10.4103/0975-7406.94154 |
work_keys_str_mv | AT lodhaa formulationandevaluationoftransparentibuprofensoftgelatincapsule AT patela formulationandevaluationoftransparentibuprofensoftgelatincapsule AT chaudhurij formulationandevaluationoftransparentibuprofensoftgelatincapsule AT jadiap formulationandevaluationoftransparentibuprofensoftgelatincapsule AT joshit formulationandevaluationoftransparentibuprofensoftgelatincapsule AT dalalj formulationandevaluationoftransparentibuprofensoftgelatincapsule |